We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+7.54%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$296M
AUM Growth
+$15.4M
Cap. Flow
-$1.17M
Cap. Flow %
-0.4%
Top 10 Hldgs %
45.09%
Holding
83
New
7
Increased
33
Reduced
28
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 29.53%
2 Financials 12.95%
3 Energy 11.42%
4 Communication Services 9.65%
5 Technology 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PACB icon
76
Pacific Biosciences
PACB
$441M
$175K 0.06%
19,500
GCVRZ
77
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$4K ﹤0.01%
14,925
-825
-5% -$209
AMLP icon
78
Alerian MLP ETF
AMLP
$13B
-4,573
Closed -$291K
GILD icon
79
Gilead Sciences
GILD
$163B
-106,027
Closed -$8.85M
PEP icon
80
PepsiCo
PEP
$191B
-2,083
Closed -$221K
TUR icon
81
iShares MSCI Turkey ETF
TUR
$209M
-47,700
Closed -$1.89M
VIXY icon
82
ProShares VIX Short-Term Futures ETF
VIXY
$190M
-19
Closed -$275K
WFC.WS
83
DELISTED
Wells Fargo & Company Ws
WFC.WS
-30,000
Closed -$409K

Similar funds

Biondo Investment Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Biondo Investment Advisors held 83 positions worth $296M, up 5.5% from $280M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Biondo Investment Advisors's Q3 2016 filing shows 7 new, 33 increased, 28 reduced and 6 closed positions. Its largest new stake was Abiomed Inc: 35,409 shares worth $4.55M. The largest sale was Gilead Sciences, an estimated $8.85M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Financials and Energy.

  • Biondo Investment Advisors's largest Q3 2016 buy was Abiomed Inc: 35,409 shares worth $4.55M.
  • Biondo Investment Advisors added most to Regeneron Pharmaceuticals in Q3 2016, an estimated $3.68M increase.
  • Biondo Investment Advisors's biggest Q3 2016 reduction was JPMorgan Chase, cutting an estimated $6.66M.
  • Biondo Investment Advisors fully exited Gilead Sciences in Q3 2016, selling an estimated $8.85M.
  • Biondo Investment Advisors's ten largest holdings make up 45% of its $296M portfolio in Q3 2016.
  • Biondo Investment Advisors opened 7 new positions and closed 6 in Q3 2016.
  • Biondo Investment Advisors's portfolio value rose 5.5% quarter-over-quarter to $296M.

Based on Biondo Investment Advisors's 13F filing for Q3 2016, filed 3 Nov 2016.